Evaluating Targeted Therapies in Ovarian Cancer Metabolism: Novel Role for PCSK9 and Second Generation mTOR Inhibitors

Dafne Jacome Sanz, Juuli Raivola, Hanna Karvonen, Mariliina Arjama, Harlan Barker, Astrid Murumägi, Daniela Ungureanu

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number3727
JournalCancers
Volume13
Issue number15
Number of pages20
ISSN2072-6694
DOIs
Publication statusPublished - Aug 2021
MoE publication typeA1 Journal article-refereed

Fields of Science

  • omentum
  • ovarian cancers
  • PCSK9
  • drug testing
  • mTOR
  • metabolism
  • rapalogs
  • MAMMALIAN TARGET
  • STRUCTURAL BASIS
  • CELL-SURVIVAL
  • DISCOVERY
  • METASTASIS
  • GROWTH
  • OPTIMIZATION
  • DEGRADATION
  • ENDOMETRIAL
  • NVP-BEZ235
  • 3122 Cancers

Cite this